SS

Shubham Shaileshbhai Koladiya

Active Director Director DIN 11151933
DIN 11151933 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shubham Shaileshbhai Koladiya

Data last updated:

Shubham Shaileshbhai Koladiya is a Director at Hemoclean Meditech Private Limited (since 2025).

DIN 11151933
Primary Designation Director
First Appointment 12 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hemoclean Meditech Private Limited U32504GJ2025PTC164059
Director12 Jun 20252025Active

Board colleagues of Shubham Shaileshbhai Koladiya

Directorship timeline

Open interactive timeline →
Hemoclean Meditech Private Limited
Premium access

Shareholding and investment profile for Shubham Shaileshbhai Koladiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubham Shaileshbhai Koladiya

Shubham Shaileshbhai Koladiya currently holds 1 directorship: Hemoclean Meditech Private Limited (Director, since 12 Jun 2025).

Shubham Shaileshbhai Koladiya was first appointed on 12 Jun 2025 as Director at Hemoclean Meditech Private Limited.

The current boards of Shubham Shaileshbhai Koladiya's companies include Harshil Rajubhai Koladiya (Hemoclean Meditech Private Limited), Sahil Pravinbhai Koladiya (Hemoclean Meditech Private Limited), Vimal Bharatbhai Koladiya (Hemoclean Meditech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available